Trump Nominates Erica Schwartz to Lead CDC
Analysis based on 81 articles · First reported Apr 15, 2026 · Last updated Apr 18, 2026
The nomination of Erica Schwartz to lead the United States===Centers for Disease Control and Prevention is expected to bring stability to the agency, potentially restoring confidence in its scientific recommendations. This move could positively impact healthcare and pharmaceutical sectors by providing clearer, more consistent public health guidance, reducing uncertainty caused by previous leadership turmoil and policy disputes.
President Donald Trump has nominated Erica Schwartz, a former deputy surgeon general, to be the next director of the United States===Centers for Disease Control and Prevention (CDC). This nomination follows a period of significant leadership instability and political controversy at the CDC, particularly concerning vaccine policies under Health Secretary Robert F. Kennedy Jr. Schwartz's appointment is seen as a more traditional choice, aiming to restore scientific integrity and public trust in the agency. Trump also announced other key appointments, including Sean Slovenski as CDC Deputy Director and Chief Operating Officer, Jennifer Shuford as CDC Deputy Director and Chief Medical Officer, and Sara Brenner as Senior Counselor for Public Health to Robert F. Kennedy Jr. The previous CDC director, Susan Monarez, was ousted after less than a month for resisting changes to the childhood vaccine schedule, leading to resignations and legal challenges against Robert F. Kennedy Jr.'s policies. The White House is reportedly seeking to temper vaccine opposition ahead of midterm elections.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard